Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.

Lameh Fananapazir(National Heart Lung and Blood Institute), Nava Epstein(University of Wisconsin–Madison), F Cyran(National Heart Lung and Blood Institute), Gabriel Cohn(National Heart Lung and Blood Institute), Marinos C. Dalakas(National and Kapodistrian University of Athens)
Proceedings of the National Academy of Sciences
May 1, 1993
10.1073/pnas.90.9.3993
Cited by 201

Related Papers

A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.
|The EMBO Journal|1991|774
Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
|Circulation|1994|383
Complement in neurological disorders and emerging complement-targeted therapeutics
|Nature Reviews Neurology|2020|354
Controlled Trial of Plasma Exchange and Leukapheresis in Polymyositis and Dermatomyositis
|New England Journal of Medicine|1992|334